BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 21064094)

  • 1. Inhibition of mammalian target of rapamycin signaling by everolimus induces senescence in adult T-cell leukemia/lymphoma and apoptosis in peripheral T-cell lymphomas.
    Darwiche N; Sinjab A; Abou-Lteif G; Chedid MB; Hermine O; Dbaibo G; Bazarbachi A
    Int J Cancer; 2011 Aug; 129(4):993-1004. PubMed ID: 21064094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-(4-hydroxyphenyl)retinamide induces growth arrest and apoptosis in HTLV-I-transformed cells.
    Darwiche N; Hatoum A; Dbaibo G; Kadara H; Nasr R; Abou-Lteif G; Bazzi R; Hermine O; de Thé H; Bazarbachi A
    Leukemia; 2004 Mar; 18(3):607-15. PubMed ID: 14712289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EAPB0203, a member of the imidazoquinoxaline family, inhibits growth and induces caspase-dependent apoptosis in T-cell lymphomas and HTLV-I-associated adult T-cell leukemia/lymphoma.
    Moarbess G; El-Hajj H; Kfoury Y; El-Sabban ME; Lepelletier Y; Hermine O; Deleuze-Masquéfa C; Bonnet PA; Bazarbachi A
    Blood; 2008 Apr; 111(7):3770-7. PubMed ID: 18218850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic trioxide and the growth of human T-cell leukemia virus type I infected T-cell lines.
    Ishitsuka K; Hanada S; Uozumi K; Utsunomiya A; Arima T
    Leuk Lymphoma; 2000 May; 37(5-6):649-55. PubMed ID: 11042529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and mechanism of action of the proteasome inhibitor PS-341 in T-cell lymphomas and HTLV-I associated adult T-cell leukemia/lymphoma.
    Nasr R; El-Sabban ME; Karam JA; Dbaibo G; Kfoury Y; Arnulf B; Lepelletier Y; Bex F; de Thé H; Hermine O; Bazarbachi A
    Oncogene; 2005 Jan; 24(3):419-30. PubMed ID: 15543232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoic acid dramatically enhances the arsenic trioxide-induced cell cycle arrest and apoptosis in retinoic acid receptor alpha-positive human T-cell lymphotropic virus type-I-transformed cells.
    Darwiche N; El-Sabban M; Bazzi R; Nasr R; Al-Hashimi S; Hermine O; de Thé H; Bazarbachi A
    Hematol J; 2001; 2(2):127-35. PubMed ID: 11424005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of survivin in HTLV-I-infected T-cell lines and primary ATL cells.
    Mori N; Yamada Y; Hata T; Ikeda S; Yamasaki Y; Tomonaga M; Yamamoto N
    Biochem Biophys Res Commun; 2001 Apr; 282(5):1110-3. PubMed ID: 11302729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Torin2 Potentiates Anticancer Effects on Adult T-Cell Leukemia/Lymphoma by Inhibiting Mammalian Target of Rapamycin.
    Watanabe T; Sato A; Kobayashi-Watanabe N; Sueoka-Aragane N; Kimura S; Sueoka E
    Anticancer Res; 2016 Jan; 36(1):95-102. PubMed ID: 26722032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual inhibition of the mTORC1 and mTORC2 signaling pathways is a promising therapeutic target for adult T-cell leukemia.
    Kawata T; Tada K; Kobayashi M; Sakamoto T; Takiuchi Y; Iwai F; Sakurada M; Hishizawa M; Shirakawa K; Shindo K; Sato H; Takaori-Kondo A
    Cancer Sci; 2018 Jan; 109(1):103-111. PubMed ID: 29077243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin suppresses constitutive activation of AP-1 by downregulation of JunD protein in HTLV-1-infected T-cell lines.
    Tomita M; Kawakami H; Uchihara JN; Okudaira T; Masuda M; Takasu N; Matsuda T; Ohta T; Tanaka Y; Mori N
    Leuk Res; 2006 Mar; 30(3):313-21. PubMed ID: 16157375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical efficacy of the synthetic retinoid ST1926 for treating adult T-cell leukemia/lymphoma.
    El Hajj H; Khalil B; Ghandour B; Nasr R; Shahine S; Ghantous A; Abdel-Samad R; Sinjab A; Hasegawa H; Jabbour M; Hall WW; Zaatari G; Dbaibo G; Pisano C; Bazarbachi A; Darwiche N
    Blood; 2014 Sep; 124(13):2072-80. PubMed ID: 25035162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of proapoptotic Bim augments IL-2-independent T-cell transformation by human T-cell leukemia virus type-1 Tax.
    Higuchi M; Takahashi M; Tanaka Y; Fujii M
    Cancer Med; 2014 Dec; 3(6):1605-14. PubMed ID: 25175936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ascorbic acid induces apoptosis in adult T-cell leukemia.
    Harakeh S; Diab-Assaf M; Khalife JC; Abu-el-Ardat KA; Baydoun E; Niedzwiecki A; El-Sabban ME; Rath M
    Anticancer Res; 2007; 27(1A):289-98. PubMed ID: 17352246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HTLV-I Tax protein inhibits apoptosis induction but not G1 arrest by pyrrolidinedithiocarbamate, an anti-oxidant, in adult T cell leukemia cells.
    Arima N; Arimura K; Tokito Y; Sakaki Y; Matsushita K; Orihara K; Akimoto M; Ozaki A; Kukita T; Hagiwara T; Hamada H; Tei C
    Exp Hematol; 2004 Feb; 32(2):195-201. PubMed ID: 15102481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bay 11-7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells.
    Mori N; Yamada Y; Ikeda S; Yamasaki Y; Tsukasaki K; Tanaka Y; Tomonaga M; Yamamoto N; Fujii M
    Blood; 2002 Sep; 100(5):1828-34. PubMed ID: 12176906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-α (IFN-α) suppresses HTLV-1 gene expression and cell cycling, while IFN-α combined with zidovudine induces p53 signaling and apoptosis in HTLV-1-infected cells.
    Kinpara S; Kijiyama M; Takamori A; Hasegawa A; Sasada A; Masuda T; Tanaka Y; Utsunomiya A; Kannagi M
    Retrovirology; 2013 May; 10():52. PubMed ID: 23688327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tax contributes apoptosis resistance to HTLV-1-infected T cells via suppression of Bid and Bim expression.
    Mühleisen A; Giaisi M; Köhler R; Krammer PH; Li-Weber M
    Cell Death Dis; 2014 Dec; 5(12):e1575. PubMed ID: 25522269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of heat shock protein-90 modulates multiple functions required for survival of human T-cell leukemia virus type I-infected T-cell lines and adult T-cell leukemia cells.
    Kawakami H; Tomita M; Okudaira T; Ishikawa C; Matsuda T; Tanaka Y; Nakazato T; Taira N; Ohshiro K; Mori N
    Int J Cancer; 2007 Apr; 120(8):1811-20. PubMed ID: 17230513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rigosertib is more potent than wortmannin and rapamycin against adult T-cell leukemia-lymphoma.
    Ghorbanzadeh Neghab M; Jalili-Nik M; Soltani A; Afshari AR; Hassanian SM; Rafatpanah H; Rezaee SA; Sadeghnia HR; Ataei Azimi S; Mashkani B
    Biofactors; 2023; 49(6):1174-1188. PubMed ID: 37345860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Bcl-2 family proteins in adult T-cell leukemia/lymphoma: in vitro and in vivo effects of the novel Bcl-2 family inhibitor ABT-737.
    Ishitsuka K; Kunami N; Katsuya H; Nogami R; Ishikawa C; Yotsumoto F; Tanji H; Mori N; Takeshita M; Miyamoto S; Tamura K
    Cancer Lett; 2012 Apr; 317(2):218-25. PubMed ID: 22138435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.